191 related articles for article (PubMed ID: 19957333)
1. Modulation of hyaluronan production by CD44 positive glioma cells.
Wiranowska M; Ladd S; Moscinski LC; Hill B; Haller E; Mikecz K; Plaas A
Int J Cancer; 2010 Aug; 127(3):532-42. PubMed ID: 19957333
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression and hyaluronic acid binding of malignant glioma cells.
Knüpfer MM; Poppenborg H; Hotfilder M; Kühnel K; Wolff JE; Domula M
Clin Exp Metastasis; 1999 Feb; 17(1):71-6. PubMed ID: 10390150
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronate receptors mediating glioma cell migration and proliferation.
Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells.
Annabi B; Thibeault S; Moumdjian R; Béliveau R
J Biol Chem; 2004 May; 279(21):21888-96. PubMed ID: 15016831
[TBL] [Abstract][Full Text] [Related]
5. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
6. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis.
Mikecz K; Dennis K; Shi M; Kim JH
Arthritis Rheum; 1999 Apr; 42(4):659-68. PubMed ID: 10211879
[TBL] [Abstract][Full Text] [Related]
7. PKC-induced stiffening of hyaluronan/CD44 linkage; local force measurements on glioma cells.
Lamontagne CA; Grandbois M
Exp Cell Res; 2008 Jan; 314(2):227-36. PubMed ID: 17698062
[TBL] [Abstract][Full Text] [Related]
8. Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?
Maherally Z; Smith JR; An Q; Pilkington GJ
PLoS One; 2012; 7(2):e30691. PubMed ID: 22363471
[TBL] [Abstract][Full Text] [Related]
9. Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level.
Klank RL; Decker Grunke SA; Bangasser BL; Forster CL; Price MA; Odde TJ; SantaCruz KS; Rosenfeld SS; Canoll P; Turley EA; McCarthy JB; Ohlfest JR; Odde DJ
Cell Rep; 2017 Jan; 18(1):23-31. PubMed ID: 28052252
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 splice variants in human primary brain tumors.
Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
Bourguignon LYW; Earle C; Shiina M
Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro.
Koochekpour S; Pilkington GJ; Merzak A
Int J Cancer; 1995 Nov; 63(3):450-4. PubMed ID: 7591247
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs.
Vogt Sionov R; Naor D
Int J Cancer; 1997 May; 71(3):462-9. PubMed ID: 9139885
[TBL] [Abstract][Full Text] [Related]
14. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
Yang T; Witham TF; Villa L; Erff M; Attanucci J; Watkins S; Kondziolka D; Okada H; Pollack IF; Chambers WH
Cancer Res; 2002 May; 62(9):2583-91. PubMed ID: 11980653
[TBL] [Abstract][Full Text] [Related]
15. Regulation of proximal tubular epithelial cell CD44-mediated binding and internalisation of hyaluronan.
Jones SG; Ito T; Phillips AO
Int J Biochem Cell Biol; 2003 Sep; 35(9):1361-77. PubMed ID: 12798349
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells.
Sugahara KN; Murai T; Nishinakamura H; Kawashima H; Saya H; Miyasaka M
J Biol Chem; 2003 Aug; 278(34):32259-65. PubMed ID: 12801931
[TBL] [Abstract][Full Text] [Related]
17. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.
Johansson E; Grassi ES; Pantazopoulou V; Tong B; Lindgren D; Berg TJ; Pietras EJ; Axelson H; Pietras A
Cell Rep; 2017 Aug; 20(7):1641-1653. PubMed ID: 28813675
[TBL] [Abstract][Full Text] [Related]
18. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices.
Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T
Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172
[TBL] [Abstract][Full Text] [Related]
19. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]